Bone mineral density in patients with primary ovarian insufficiency: A systematic review and Meta-Analysis

Eur J Obstet Gynecol Reprod Biol. 2024 Apr:295:219-227. doi: 10.1016/j.ejogrb.2024.02.013. Epub 2024 Feb 10.

Abstract

Introduction: Premature menopause is a major complication of primary ovarian insufficiency (POI), and this loss is closely relates to bone mineral density (BMD). Previous research has indicated potential associations between BMD and POI. This study set out to provide the first systematic literature review and meta-analysison account of BMD content among women with POI.

Methods: Studies including women with POI and controls were eligible from PubMed, Embase, Cochrane Library and Web of Science databases (from their inception to April 2022). Two reviewers independently evaluated study eligibility. The meta-analysis was performed using the DerSimonian and Laird random effects model.

Results: Ten studies featuring 578 women with POI and 480 controls were selected. BMD content of femur neck (SMD:-0.76; 95 % CI: -1.20 to -0.31; P = 0.0008), the BMD content of nondominating forearm (SMD:-0.67; 95 % CI: -1.15 to -0.18; P = 0.007) were significantly decreased in women with POI. However, no differences were seen in other regions (lumbar spine, total hip, hipneck).

Discussion: The results of this study indicate that BMD content altered in patients with primary ovarian insufficiency. An implication of this is the possibility that hormone replacement therapy to minimize the prevalence of fracture morbidity and mortality associated with osteopenia in patients with POI.

Keywords: Bone mineral density; Hormone replacement therapy; Meta-analysis; Osteopenia; Osteoporosis; Primary ovarian insufficiency.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Bone Density
  • Female
  • Fractures, Bone*
  • Hormone Replacement Therapy
  • Humans
  • Osteoporosis, Postmenopausal*
  • Primary Ovarian Insufficiency* / complications